Fundraising FoxMVM Life Science Partners — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
CurvaFix develops the CurvaFix Low Profile intramedullary nailing system, curved implants for surgical stabilization of pelvic fractures.
HardwareHealthtechMedical DevicesBellevue, US
Jeffrey Poole(Executive Officer)Mark Foster(Executive Officer, Director)inSteven Dimmer(Executive Officer, Director, Promoter)Dong-Gun Kim(Director)
Board seatJack TanakaEric Fritz· per SEC Form D
Co-investorsAlliance of AngelsArieal Southeast Angel PartnersRockies Venture ClubSPRINGROCK VENTURESSwan Venture FundKeiretsu Capital+2 more
FemTechHealthtechMedical DevicesRedwood City, US
Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)
BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)inDoug Fisher(Director)
Board seatHugo Harrod· per SEC Form D · $92.2M raise · filed Nov 2023
Co-investorsAmzak HealthBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz Ventures+6 more
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells.
BiotechHealthtechMedical Devices
David G. Brachman, MD, FASTRO(Co-Founder and Chief Technology Officer)Heyoung McBride, MD, MS, FASTRO(Co-Founder)Peter Nakaji, MD(Co-Founder)inEmad Youssef, MD(Co-Founder)Theresa Thomas, MS, CCRC(Co-Founder)Per Langoe(Chief Executive Officer)in
Co-investorsAccelmed PartnersBlueStone Venture PartnersEvidity Health CapitalFemHealth VenturesGilde HealthcareMedTech Venture Partners+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.